SEARL has concluded an exclusive licensing & supply agreement with Livzon Mapharm Inc

SEARL in a notice informed that it has concluded an exclusive licensing & supply agreement with Livzon Mapharm Inc for the “recombinant novel coronavirus vaccine(V-01)’ which also covers manufacturing transition of (V-01) in Pakistan.

spot_img

More like this

KSE 100 Skyrockets to Historic 78k Milestone!

The Pakistan Stock Exchange (PSX) experienced a buying frenzy as the benchmark KSE-100 index surged by over...

KSE-100 Index soars with record-breaking single-day gain of 3,411...

Bulls added 3,411 points (↑ 4.69%) to the KSE – 100 Index to close at 76,208 level....

“Riding the Wave: KSE-100 Index Soars Amid Post-Budget Euphoria”

The Pakistan Stock Exchange (PSX) opened on an overwhelmingly positive note in the post-budget session as the...